Thought Leadership

Explore published articles, interviews, and blog posts from leading IP professionals.

Blog | February 12, 2014

Hatch-Waxman safe harbor expansion continues

Fish & Richardson
Read more
Article | February 12, 2014

New Internet Domain Name Options Available for Pharma Industry

Pharmaceutical Compliance Monitor

Read more
Blog | January 28, 2014

New FCC Rules Require Part 5 Experimental Licenses

Fish & Richardson

Read more
Blog | January 27, 2014

NDGA rejects two-supplier market theory for lost profits

Fish & Richardson
Read more
Blog | January 23, 2014

Federal Circuit Decision on Patent Term Adjustment

Fish & Richardson

Read more
Blog | January 17, 2014

EDTX admits plaintiff's EMVR testimony

Fish & Richardson
Read more
Blog | January 15, 2014

180-Day Statute of Limitations Under 35 U.S.C. 154(b)(3) & (4) Applies to Final Patent Term Adjustment Determinations, Although Time Between Allowance and Issuance Should Not Be Excluded

Fish & Richardson
Read more
Blog | January 15, 2014

EDTX allows cost savings approach for royalties, based on cost of entire location network

Fish & Richardson
Read more
Blog | January 13, 2014

SDNY grants SJ of no pre-notice damages where plaintiff failed to plead marking

Fish & Richardson
Read more
Blog | December 24, 2013

SDNY comments on EMVR's application in pharma context

Fish & Richardson
Read more
Blog | December 23, 2013

DUtah Uses Infringer's Profits to Compute Royalty; Comments on Obligation to Award Reasonable Royalty

Fish & Richardson
Read more
Article | December 20, 2013

Timing of PTO Disclosures - A Trap for the Unwary

Pharmaceutical Compliance Monitor

Read more